116 related articles for article (PubMed ID: 16819834)
1. The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR.
Nygaard R; Nielbo S; Schwartz TW; Poulsen FM
Biochemistry; 2006 Jul; 45(27):8350-7. PubMed ID: 16819834
[TBL] [Abstract][Full Text] [Related]
2. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
3. Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivity.
Pedersen SL; Holst B; Vrang N; Jensen KJ
J Pept Sci; 2009 Nov; 15(11):753-9. PubMed ID: 19739125
[TBL] [Abstract][Full Text] [Related]
4. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
[TBL] [Abstract][Full Text] [Related]
5. Glyco-scan: varying glycosylation in the sequence of the peptide hormone PYY3-36 and its effect on receptor selectivity.
Pedersen SL; Steentoft C; Vrang N; Jensen KJ
Chembiochem; 2010 Feb; 11(3):366-74. PubMed ID: 20049760
[TBL] [Abstract][Full Text] [Related]
6. Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active.
Germain N; Minnion JS; Tan T; Shillito J; Gibbard C; Ghatei M; Bloom S
Peptides; 2013 Jan; 39():6-10. PubMed ID: 23123314
[TBL] [Abstract][Full Text] [Related]
7. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
[TBL] [Abstract][Full Text] [Related]
8. Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.
Pedersen SL; Sasikumar PG; Chelur S; Holst B; Artmann A; Jensen KJ; Vrang N
J Pept Sci; 2010 Nov; 16(11):664-73. PubMed ID: 20853314
[TBL] [Abstract][Full Text] [Related]
9. Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helix variants of PYY3-36.
Pedersen SL; Bhatia VK; Jurt S; Paulsson JF; Pedersen MH; Jorgensen R; Holst B; Stamou D; Vrang N; Zerbe O; Jensen KJ
J Pept Sci; 2012 Sep; 18(9):579-87. PubMed ID: 22865741
[TBL] [Abstract][Full Text] [Related]
10. The role of PYY in feeding regulation.
Ueno H; Yamaguchi H; Mizuta M; Nakazato M
Regul Pept; 2008 Jan; 145(1-3):12-6. PubMed ID: 17920705
[TBL] [Abstract][Full Text] [Related]
11. Properties of the N-terminal domains from Y receptors probed by NMR spectroscopy.
Zou C; Kumaran S; Walser R; Zerbe O
J Pept Sci; 2009 Mar; 15(3):184-91. PubMed ID: 19125388
[TBL] [Abstract][Full Text] [Related]
12. PYY regulates pancreatic exocrine secretion through multiple receptors in the awake rat.
Guarita DR; Deng X; Huh YB; Wood PG; Reeve JR; Whitcomb DC
Dig Dis Sci; 2000 Sep; 45(9):1696-702. PubMed ID: 11052307
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of monomeric peptide YY supports the functional significance of the PP-fold.
Keire DA; Kobayashi M; Solomon TE; Reeve JR
Biochemistry; 2000 Aug; 39(32):9935-42. PubMed ID: 10933813
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
15. Design of Y
Østergaard S; Kofoed J; Paulsson JF; Madsen KG; Jorgensen R; Wulff BS
J Med Chem; 2018 Dec; 61(23):10519-10530. PubMed ID: 30399314
[TBL] [Abstract][Full Text] [Related]
16. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
[TBL] [Abstract][Full Text] [Related]
17. Structure and receptor binding of PYY analogs.
Keire DA; Bowers CW; Solomon TE; Reeve JR
Peptides; 2002 Feb; 23(2):305-21. PubMed ID: 11825645
[TBL] [Abstract][Full Text] [Related]
18. Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
Haack M; Beck-Sickinger AG
Chem Biol Drug Des; 2009 Jun; 73(6):573-83. PubMed ID: 19635049
[TBL] [Abstract][Full Text] [Related]
19. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
[TBL] [Abstract][Full Text] [Related]
20. A parallel semisynthetic approach for structure-activity relationship studies of peptide YY.
Albertsen L; Østergaard S; Paulsson JF; Norrild JC; Strømgaard K
ChemMedChem; 2013 Sep; 8(9):1505-13, 1422. PubMed ID: 23907926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
